Home
About
Directory
Promoted Listings
Purchase Data
Drug Pipelines
Data Licensing
Newsletter
Contact
EngMab
is defunct.
Bought by Celgene, Sep 2016, $625M + $2.4B milestones
------------------
If you believe any of this information is incorrect, please
let us know
.